글로벌 척추 자극기 시장 (2023-2032) : 충전식 장치, 비충전식 장치

■ 영문 제목 : Spinal Cord Stimulation Devices Market By Product (Rechargeable devices, Non-rechargeable devices), By Indication (Failed back surgery syndrome, Complex regional pain syndrome, Degenerative disc disease, Others), By End User (Hospitals, Ambulatory surgical centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Allied Market Research가 발행한 조사보고서이며, 코드는 ALD23SEP138 입니다.■ 상품코드 : ALD23SEP138
■ 조사/발행회사 : Allied Market Research
■ 발행일 : 2023년 5월
■ 페이지수 : 258
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 세계
■ 판매가격 / 옵션 (부가세 10% 별도)
Single UserUSD5,730 ⇒환산₩7,735,500견적의뢰/주문/질문
5 UserUSD6,450 ⇒환산₩8,707,500견적의뢰/주문/질문
Enterprise UserUSD9,600 ⇒환산₩12,960,000견적의뢰/구입/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
척수 자극은 만성 통증 질환 환자의 통증을 줄이고 기능을 개선하기 위해 척수에 전기 충격을 전달하는 이식형 장치를 사용하는 의료 기술입니다. 척추 자극기는 피부 아래, 허리에 이식되는 소형 배터리 구동식 발전기와 척수 근처의 경막외 공간에 이식되는 하나 이상의 리드로 구성됩니다. 리드는 발전기에 연결되어 척수에 전기 충격을 전달하여 통증 신호가 뇌에 도달하는 것을 차단하거나 방해합니다. 척추 자극기는 허리 수술 실패 증후군(FBSS), 복합부위 통증 증후군(CRPS), 퇴행성 디스크 질환(DDD), 통증성 당뇨병성 신경병증(PDN) 등 다양한 질환을 치료하는 데 사용됩니다. 척추 자극기는 다양한 기능과 성능을 갖춘 다양한 유형과 디자인으로 제공됩니다. 충전식 및 비충전식 장치와 같은 다양한 유형의 척수 자극은 다양한 환자의 요구를 해결하고 맞춤형 치료 옵션을 제공하도록 설계되었습니다.
척추 자극기 시장의 성장을 이끄는 주요 요인은 만성 통증 질환으로 고통받는 사람들의 수 증가, 척추 자극기의 기술 발전 및 척추 자극기의 채택 증가입니다. 만성 통증은 허리 수술 실패 증후군(FBSS), 복합부위 통증 증후군(CRPS), 퇴행성 디스크 질환(DDD), 당뇨병성 신경병증과 같은 다양한 질환으로 인해 발생할 수 있습니다. 이러한 질환은 신체를 쇠약하게 하여 삶의 질에 영향을 미치고 장기적인 관리가 필요할 수 있습니다. 척추 자극기는 다른 형태의 치료에 반응하지 않는 만성 통증 질환을 앓고 있는 환자에게 효과적인 치료 옵션으로 부상했습니다. 또한 척추 자극기는 척수에 전기 자극을 전달하여 통증 신호가 뇌로 전달되는 것을 방해하는 방식으로 작동합니다.

또한 척추 자극기의 기술 발전으로 장치가 더 작고 유연하며 더 효과적이 되었습니다. 예를 들어, 최신 기기는 고주파 자극을 사용하여 기존의 저주파 자극과 관련된 따끔거림이나 찌릿한 감각을 유발하지 않으면서 통증을 완화할 수 있습니다. 또한 충전식 배터리와 무선 장치가 개발되어 환자의 편안함과 편의성을 개선하는 등 다른 발전도 이루어지고 있습니다. 이러한 기술 발전은 환자와 의사가 보다 효과적이고 사용자 친화적인 장치를 찾음에 따라 척추 자극기에 대한 수요를 촉진할 것으로 예상됩니다.

또한 전 세계 인구가 빠르게 고령화되고 있으며 이러한 인구 통계학적 변화는 척추 자극기에 대한 수요를 견인할 것으로 예상됩니다. 노년층은 만성 통증 질환을 앓을 가능성이 높으며, 인구 고령화에 따라 척수 자극 치료가 필요한 사람의 수가 증가할 것으로 예상됩니다. 예를 들어, 2022년 미국 인구조사국에 따르면 미국 내 65세 이상 성인 인구는 5,600만 명 이상으로 미국 전체 인구의 약 16.9%를 차지하므로 노인 인구의 증가는 시장 성장을 촉진할 것으로 예상됩니다.

척추 자극기 시장은 제품, 적응증, 최종 용도 및 지역으로 세분화됩니다. 제품을 기준으로 시장은 충전식 장치와 비 충전식 장치로 나뉩니다. 적응증에 따라 허리 수술 실패 증후군, 복합 부위 통증 증후군, 퇴행성 디스크 질환 및 기타로 분류됩니다. 최종 용도에 따라 병원, 외래 수술 센터 및 기타로 구분됩니다. 지역별로는 북미(미국, 캐나다, 멕시코), 유럽(독일, 프랑스, 영국, 이탈리아, 스페인 및 기타 유럽 지역), 아시아 태평양(일본, 중국, 호주, 인도, 한국 및 기타 아시아 태평양) 및 중남미/중동/아프리카(라틴 아메리카 및 중동 아프리카) 시장을 분석합니다.
글로벌 척추 자극기 시장에서 활동하는 주요 주요 업체는 Medtronic Plc, Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, Beijing PINS Medical Co., Ltd, Saluda Medical Pty Ltd., Nalu Medical, Inc., BIOTRONIK, GIMER MEDICAL, and Teliatry, Inc. 등입니다. 주요 업체들은 제품 포트폴리오를 확장하기 위해 인수, 제품 출시, 제품 승인 및 확장과 같은 전략을 채택했습니다.

이해 관계자를 위한 주요 이점
이 보고서는 2022년부터 2032년까지 척추 자극기 시장 분석의 시장 부문, 현재 동향, 추정 및 역학에 대한 정량적 분석을 제공하여 지배적인 척추 자극기 시장 기회를 식별합니다.
시장 조사는 주요 동인, 제약 및 기회와 관련된 정보와 함께 제공됩니다.
포터의 다섯 가지 경쟁 요인 분석은 이해 관계자가 이익 지향적인 비즈니스 결정을 내리고 공급 업체-구매자 네트워크를 강화할 수 있도록 구매자와 공급 업체의 힘을 강조합니다.
척추 자극기 시장 세분화에 대한 심층 분석은 일반적인 시장 기회를 결정하는 데 도움이 됩니다.
각 지역의 주요 국가는 글로벌 시장에 대한 수익 기여도에 따라 매핑됩니다.
시장 플레이어 포지셔닝은 벤치마킹을 용이하게하고 시장 플레이어의 현재 위치에 대한 명확한 이해를 제공합니다.
이 보고서에는 지역 및 글로벌 척추 자극기 시장 동향, 주요 업체, 시장 세그먼트, 응용 분야 및 시장 성장 전략에 대한 분석이 포함되어 있습니다.

주요 시장 부문
질환별
허리 수술 실패 증후군
복합부위 통증 증후군
퇴행성 디스크 질환
기타

제품별
충전식 기기
비충전식 기기

최종 용도별
병원
외래 수술 센터
기타

지역별
북미
미국
캐나다
멕시코
유럽
독일
프랑스
영국
이탈리아
스페인
기타 유럽 지역
아시아 태평양
일본
중국
인도
호주
한국
기타 아시아 태평양 지역
중남미/중동/아프리카
라틴 아메리카
중동 아프리카

주요 기업
○ Boston Scientific Corporation
○ Beijing PINS Medical Co., Ltd
○ Medtronic plc
○ Abbott Laboratories
○ BIOTRONIK SE & Co. KG
○ Saluda Medical Pty Ltd.
○ Nalu Medical, Inc.
○ GIMER MEDICAL
○ Teliatry, Inc.
○ Nevro Corporation
■ 보고서 개요

CHAPTER 1 : 소개
CHAPTER 2 : 개요
CHAPTER 3 : 시장 동향
CHAPTER 4 : 척추 자극기 시장, 제품별
CHAPTER 5 : 척추 자극기 시장, 질환별
CHAPTER 6 : 척추 자극기 시장, 최종 용도별
CHAPTER 7 : 척추 자극기 시장, 지역별
CHAPTER 8 : 경쟁 현황
CHAPTER 9 : 기업 정보

■ 보고서 목차

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence of chronic pain conditions
3.4.1.2. Technological advancements in spinal cord stimulation devices
3.4.1.3. Availability of medical reimbursement schemes

3.4.2. Restraints
3.4.2.1. High cost and side effects of spinal cord stimulation devices
3.4.2.2. Availability of alternative treatment options for chronic pain

3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Rechargeable devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Non-rechargeable devices
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Failed back surgery syndrome
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Complex regional pain syndrome
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Degenerative disc disease
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: SPINAL CORD STIMULATION DEVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory surgical centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: SPINAL CORD STIMULATION DEVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product
7.2.3. Market size and forecast, by Indication
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product
7.2.5.1.3. Market size and forecast, by Indication
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product
7.2.5.2.3. Market size and forecast, by Indication
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product
7.2.5.3.3. Market size and forecast, by Indication
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product
7.3.3. Market size and forecast, by Indication
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product
7.3.5.1.3. Market size and forecast, by Indication
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product
7.3.5.2.3. Market size and forecast, by Indication
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product
7.3.5.3.3. Market size and forecast, by Indication
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product
7.3.5.4.3. Market size and forecast, by Indication
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product
7.3.5.5.3. Market size and forecast, by Indication
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product
7.3.5.6.3. Market size and forecast, by Indication
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product
7.4.3. Market size and forecast, by Indication
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product
7.4.5.1.3. Market size and forecast, by Indication
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product
7.4.5.2.3. Market size and forecast, by Indication
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product
7.4.5.3.3. Market size and forecast, by Indication
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product
7.4.5.4.3. Market size and forecast, by Indication
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product
7.4.5.5.3. Market size and forecast, by Indication
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product
7.4.5.6.3. Market size and forecast, by Indication
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product
7.5.3. Market size and forecast, by Indication
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Latin America
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product
7.5.5.1.3. Market size and forecast, by Indication
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Middle East Africa
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product
7.5.5.2.3. Market size and forecast, by Indication
7.5.5.2.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Boston Scientific Corporation
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Medtronic plc
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Abbott Laboratories
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Nevro Corporation
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Beijing PINS Medical Co., Ltd
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Saluda Medical Pty Ltd.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Key strategic moves and developments
9.7. Nalu Medical, Inc.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Teliatry, Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. GIMER MEDICAL
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Key strategic moves and developments
9.10. BIOTRONIK SE & Co. KG
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Key strategic moves and developments

LIST OF TABLES
TABLE 01. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. SPINAL CORD STIMULATION DEVICES MARKET FOR RECHARGEABLE DEVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 03. SPINAL CORD STIMULATION DEVICES MARKET FOR NON-RECHARGEABLE DEVICES, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 05. SPINAL CORD STIMULATION DEVICES MARKET FOR FAILED BACK SURGERY SYNDROME, BY REGION, 2022-2032 ($MILLION)
TABLE 06. SPINAL CORD STIMULATION DEVICES MARKET FOR COMPLEX REGIONAL PAIN SYNDROME, BY REGION, 2022-2032 ($MILLION)
TABLE 07. SPINAL CORD STIMULATION DEVICES MARKET FOR DEGENERATIVE DISC DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 08. SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 09. GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 10. SPINAL CORD STIMULATION DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. SPINAL CORD STIMULATION DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. SPINAL CORD STIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 13. SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 18. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 19. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 20. U.S. SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 21. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 22. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 23. CANADA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 24. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 25. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 26. MEXICO SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 27. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 28. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 29. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 30. EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 31. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 32. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 33. GERMANY SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 34. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 35. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 36. FRANCE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 37. UK SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 38. UK SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 39. UK SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 40. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 41. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 42. ITALY SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 43. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 44. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 45. SPAIN SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 49. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 53. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 54. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 55. JAPAN SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 56. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 57. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 58. CHINA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 59. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 60. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 61. INDIA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 64. AUSTRALIA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 65. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 71. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 72. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 73. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 74. LAMEA SPINAL CORD STIMULATION DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 75. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 76. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 77. LATIN AMERICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 78. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 79. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 80. MIDDLE EAST AFRICA SPINAL CORD STIMULATION DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 81. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 82. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 83. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
TABLE 84. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 85. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 86. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 87. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 88. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 89. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 90. MEDTRONIC PLC: KEY STRATERGIES
TABLE 91. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 92. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 93. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 94. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 95. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 96. NEVRO CORPORATION: KEY EXECUTIVES
TABLE 97. NEVRO CORPORATION: COMPANY SNAPSHOT
TABLE 98. NEVRO CORPORATION: PRODUCT SEGMENTS
TABLE 99. NEVRO CORPORATION: PRODUCT PORTFOLIO
TABLE 100. NEVRO CORPORATION: KEY STRATERGIES
TABLE 101. BEIJING PINS MEDICAL CO., LTD: KEY EXECUTIVES
TABLE 102. BEIJING PINS MEDICAL CO., LTD: COMPANY SNAPSHOT
TABLE 103. BEIJING PINS MEDICAL CO., LTD: PRODUCT SEGMENTS
TABLE 104. BEIJING PINS MEDICAL CO., LTD: PRODUCT PORTFOLIO
TABLE 105. SALUDA MEDICAL PTY LTD.: KEY EXECUTIVES
TABLE 106. SALUDA MEDICAL PTY LTD.: COMPANY SNAPSHOT
TABLE 107. SALUDA MEDICAL PTY LTD.: PRODUCT SEGMENTS
TABLE 108. SALUDA MEDICAL PTY LTD.: PRODUCT PORTFOLIO
TABLE 109. SALUDA MEDICAL PTY LTD.: KEY STRATERGIES
TABLE 110. NALU MEDICAL, INC.: KEY EXECUTIVES
TABLE 111. NALU MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 112. NALU MEDICAL, INC.: PRODUCT SEGMENTS
TABLE 113. NALU MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 114. TELIATRY, INC.: KEY EXECUTIVES
TABLE 115. TELIATRY, INC.: COMPANY SNAPSHOT
TABLE 116. TELIATRY, INC.: PRODUCT SEGMENTS
TABLE 117. TELIATRY, INC.: PRODUCT PORTFOLIO
TABLE 118. GIMER MEDICAL: KEY EXECUTIVES
TABLE 119. GIMER MEDICAL: COMPANY SNAPSHOT
TABLE 120. GIMER MEDICAL: PRODUCT SEGMENTS
TABLE 121. GIMER MEDICAL: PRODUCT PORTFOLIO
TABLE 122. GIMER MEDICAL: KEY STRATERGIES
TABLE 123. BIOTRONIK SE & CO. KG: KEY EXECUTIVES
TABLE 124. BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
TABLE 125. BIOTRONIK SE & CO. KG: PRODUCT SEGMENTS
TABLE 126. BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
TABLE 127. BIOTRONIK SE & CO. KG: KEY STRATERGIES
※본 조사보고서 [글로벌 척추 자극기 시장 (2023-2032) : 충전식 장치, 비충전식 장치] (코드 : ALD23SEP138) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [글로벌 척추 자극기 시장 (2023-2032) : 충전식 장치, 비충전식 장치] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!